Background The combination of chemotherapy with thoracic radiotherapy (TRT) compared
with TRT alone has been shown to confer a survival advantage for good performance status …

PURPOSE: A phase III study was performed to determine whether concurrent or sequential
treatment with radiotherapy (RT) and chemotherapy (CT) improves survival in unresectable …

Purpose This phase III trial of concurrent thoracic radiotherapy (TRT) was conducted to
compare third-generation chemotherapy with second-generation chemotherapy in patients …

Background The optimal chemotherapy regimen administered currently with radiation in
patients with stage III non-small cell lung cancer (NSCLC) remains unclear. A multicenter …

Purpose: This Phase III study was performed to determine whether chemotherapy plus bid or
qd radiotherapy (RT) resulted in superior survival for patients with Stage III non-small-cell …

Purpose We conducted a phase III study to compare the survival impact of concurrent versus
sequential treatment with radiotherapy (RT) and chemotherapy (CT) in unresectable stage III …

Purpose: This trial was performed to determine the maximum tolerated dose (MTD) of
radiation that can be administered with carboplatin and paclitaxel. Methods and Materials …

Purpose To evaluate 74 Gy thoracic radiation therapy (TRT) with induction and concurrent
chemotherapy in stage IIIA/B non–small-cell lung cancer (NSCLC). Patients and Methods …

Purpose: The purpose of this study was to assess response, toxicity, failure patterns, and
survival differences in three chemotherapy (ChT)/radiation therapy (RT) sequencing …

PURPOSE: There are no published survival data after chemoradiotherapy (chemoRT) in
pathologically documented stage IIIB non–small-cell lung cancer. Studies of radiotherapy …